Share chart YiChang HEC ChangJiang Pharmaceutical Co., Ltd.
About YiChang HEC ChangJiang Pharmaceutical Co., Ltd.
YiChang HEC ChangJiang Pharmaceutical Co., Ltd. разрабатывает, производит и продает фармацевтические препараты для лечения антивирусных, эндокринных и метаболических заболеваний, а также сердечно-сосудистых заболеваний в Китайской Народной Республике. Он также производит и продает активные фармацевтические ингредиенты; исследует и разрабатывает медицинские устройства и лекарства, а также биотехнологии; и оказывает медицинские консультационные услуги. Компания реализует свою продукцию больницам и лечебным учреждениям через сеть дистрибьюторов. more details| ISIN | CNE1000023R6 |
|---|---|
| Industry | Pharmaceuticals |
| Sector | Health Care |
| Валюта | hkd |
| Валюта отчета | cny |
| Див.доход ао | 10.12 |
| Дивиденд ао | 0.4416 |
| Сайт | https://www.hec-changjiang.com |
| Цена ао | 9.85 |
| Change price per day: | 0% (11.9) |
|---|---|
| Change price per week: | +14.42% (10.4) |
| Change price per month: | +21.3% (9.81) |
| Change price per 3 month: | +24.61% (9.55) |
| Change price per half year: | +32.08% (9.01) |
| Change price per year: | -3.72% (12.36) |
| Change price per 3 year: | +142.36% (4.91) |
| Change price per 5 year: | -74.73% (47.1) |
| Change price per year to date: | +25% (9.52) |
|
|
Underestimation
|
Efficiency
|
|||||||||||||||||||||||||||||||||||||
Dividends
|
Debt
|
Growth impulse
|
|||||||||||||||||||||||||||||||||||||
| Institutions | Volume | Share, % |
|---|---|---|
| Vanguard International Stock Index-Total Intl Stock Indx | 5576264 | 0.85 |
| Vanguard International Stock Index-Emerging Markets Stk | 5144164 | 0.79 |
| DFA Emerging Markets Core Equity Portfolio | 1663000 | 0.25 |
| Vanguard Intl Equity Index Fds-FTSE All World ex U.S.Small Cap Index | 1534400 | 0.23 |
| DFA Investment Dimensions-DFA Emerging Mkts Value | 1474600 | 0.23 |
| iShares Core MSCI Emerging Markets ETF | 994200 | 0.15 |
| DFA Emerging Markets Small Cap Series | 818800 | 0.13 |
| Avantis Emerging Markets Equity ETF | 506600 | 0.08 |
| Avantis Emerging Markets Equity Fund | 506600 | 0.08 |
| Dimensional ETF Tr-Dimensional Emerging Markets Core Equity 2 ETF | 270200 | 0.04 |
| Head | Job title | Payment | Year of birth |
|---|---|---|---|
| Mr. Juncai Jiang | GM & Executive Director | 1.38M | 1982 (43 years) |
| Mr. Qiang Zhang | CFO & Head of Finance Department | 520.55k | 1977 (48 years) |
| Mr. Yangui Chen | Head of the Sales Department | 1.12M | 1981 (44 years) |
| Mr. Danjin Wang | Deputy GM & Executive Director | 993.68k | 1970 (55 years) |
| Mr. Shuang Li | Deputy GM & Executive Director | 864.73k | 1981 (44 years) |
| Mr. Qiyun Peng | Joint Company Secretary | 401.28k | 1991 (34 years) |
| Mr. Shengchao Wang | Chief of Quality Division & Employee Representative Supervisor | N/A | 1982 (43 years) |
| Mr. Wai Chiu Wong FCS | Joint Company Secretary | N/A | 1955 (70 years) |
| Mr. Hao Chen | Executive Director | N/A | 1975 (50 years) |
Address: China, Yichang, No. 38 Binjiang Road - open in Google maps, open in Yandex maps
Website: https://www.hec-changjiang.com
Website: https://www.hec-changjiang.com
